Purple Biotech Ltd. (PPBT)
3.33
-0.08 (-2.35%)
At close: Jan 29, 2025, 3:59 PM
3.36
0.90%
After-hours Jan 29, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -19.88M | -21.76M | -17.83M | -28.07M | -5.89M | -5.57M | -13.01M | -12.13M | -4.20M | -5.25M | -2.63M | -703 |
| Depreciation & Amortization | 197.00K | 201.00K | 231.00K | 235.00K | 179.00K | 7.00K | 4.00K | 2.00K | 1K | n/a | n/a | n/a |
| Stock-Based Compensation | 1.88M | 2.41M | 2.08M | 2.65M | 1.27M | 773.00K | 2.31M | 400.00K | 59.00K | 88.00K | 296.00K | n/a |
| Other Working Capital | -1.24M | 2.14M | 27.00K | -20.00K | -163.00K | -933.00K | 613.00K | 407.00K | 185.00K | -583.00K | 145.00K | n/a |
| Other Non-Cash Items | -931.00K | -843.00K | -108.00K | 15.46M | -1.48M | -3.15M | 1.95M | 5.19M | 550.00K | 768.00K | 1.69M | 450.00 |
| Deferred Income Tax | -761.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 274.00K | 3.25M | 550.00K | -2.36M | 340.00K | -540.00K | 122.00K | 269.00K | 284.00K | -130.00K | 134.00K | -1 |
| Operating Cash Flow | -19.23M | -16.73M | -15.07M | -12.09M | -5.58M | -8.48M | -8.63M | -6.26M | -3.31M | -4.53M | -512.00K | -253 |
| Capital Expenditures | -3.00K | -228.00K | -115.00K | -156.00K | -11.00K | -16.00K | -13.00K | -10.00K | -9.00K | n/a | n/a | n/a |
| Acquisitions | -3.55M | n/a | n/a | 69.00K | n/a | n/a | -1.73M | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -17.43K | n/a | n/a | -49.62M | -2.10M | n/a | n/a | -7.90M | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 16.68M | 19.82M | 13.16M | 41.00K | 1.51M | 1.97M | 4.41M | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | 772.43K | 324.00K | 359.00K | 69.00K | 151.00K | 2.06M | 4.52M | -7.90M | n/a | n/a | n/a | n/a |
| Investing Cash Flow | 13.88M | 19.91M | 13.41M | -49.59M | -449.00K | 2.04M | 2.77M | -7.91M | -9.00K | n/a | n/a | n/a |
| Debt Repayment | -168.00K | -165.00K | -153.00K | -179.00K | -171.00K | n/a | n/a | n/a | n/a | n/a | 686.00K | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 4.05M | -219.00K | 1.10M | 40.74M | 2.81M | 3.10M | 576.00K | 4.00M | -2.31M | -1.03M | 15.00K | 253.00 |
| Financial Cash Flow | 5.45M | 1.11M | 1.51M | 68.49M | 5.23M | 7.79M | 3.00M | 10.42M | 12.63M | 5.82M | 701.00K | 253.00 |
| Net Cash Flow | -541.00K | 4.14M | -357.00K | 6.86M | -778.00K | 1.22M | -2.81M | -3.80M | 9.24M | 1.12M | 193.00K | n/a |
| Free Cash Flow | -19.23M | -16.96M | -15.19M | -12.25M | -5.59M | -8.50M | -8.64M | -6.27M | -3.32M | -4.53M | -512.00K | -253 |